Cancer drug listing

Drug name(s)

Oncaspar® PEG-L-asparaginase Pegaspargase

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)

Drug name(s)

Neulasta® Pegfilgrastim G-CSF Fulphila™ * Pegfilgrastim-jmdb* Udenyca™ * Pegfilgrastim-cbqv* Ziextenzo™ * Pegfilgrastim-bmez * Nyvepria Pegfilgrastim-apgf* Fylnetra* Pegfilgrastim-pbbk* Stimufend®* Pegfilgrastim-fpgk*

Approved for

• Other Blood Cancers

Drug name(s)

Keytruda® Pembrolizumab

Approved for

• Lymphoma
• Hodgkin Lymphoma (HL)
• Primary Mediastinal (Thymic) Large B-cell Lymphoma (PMBCL)
• Other Blood Cancers

Drug name(s)

Nipent® Pentostatin

Approved for

• Leukemia
• Hairy Cell Leukemia (HCL)
• Essential Thrombocythemia
• Other Blood Cancers

Drug name(s)

Pirtobrutinib Jaypirca®

Approved for

• Chronic Lymphocytic Leukemia (CLL/SLL)
• Lymphoma
• Mantle Cell Lymphoma (MCL) 

Drug name(s)

Pivekimab sunirine-pvzy Decnupaz™

Approved for

• Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Drug name(s)

Mozobil® Plerixafor

Approved for

• Lymphoma
• Non-Hodgkin Lymphoma (NHL)
• Myeloma

Drug name(s)

Polivy® Polatuzumab vedotin-piiq

Approved for

• Lymphoma
• Diffuse Large B-cell Lymphoma (DLBCL) 
• Other Blood Cancers

Drug name(s)

Pomalyst® Pomalidomide

Approved for

• Myeloma

Drug name(s)

Iclusig® Ponatinib

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Chronic Myeloid Leukemia (CML)

Drug name(s)

Folotyn® Pralatrexate

Approved for

• Large B-Cell Lymphoma (LBCL)
• Lymphoma
• Adult T-cell Leukemia/Lymphoma
• Other Blood Cancers

Drug name(s)

Matulane® Procarbazine

Approved for

• Lymphoma
• Hodgkin Lymphoma (HL)

Drug name(s)

Quizartinib Vanflyta®

Approved for

• Acute Myeloid Leukemia (AML)

Drug name(s)

Elitek® Rasburicase

Approved for

• Leukemia
• Lymphoma

Drug name(s)

Ryoncil® Remestemcel-L-rknd

Drug name(s)

Revumenib Revuforj®

Approved for

• Acute Lymphoblastic Leukemia (ALL)
• Acute Myeloid Leukemia (AML)

Drug name(s)

Rituxan® Rituximab Truxima® * Rituximab-abbs* Ruxience™ * Rituximab-pvvr* Riabni Rituximab-arrx*

Approved for

• Leukemia
• Chronic Lymphocytic Leukemia (CLL/SLL)
• B-Cell Prolymphocytic Leukemia
• Lymphoma
• Non-Hodgkin Lymphoma (NHL)
• Burkitt Lymphoma (BL)
• Diffuse Large B-cell Lymphoma (DLBCL) 

Drug name(s)

Rituxan Hycela® Rituximab and hyaluronidase human

Approved for

• Leukemia
• Chronic Lymphocytic Leukemia (CLL/SLL)
• Lymphoma
• Diffuse Large B-cell Lymphoma (DLBCL) 
• Follicular Lymphoma (FL) 

Drug name(s)

Istodax® Romidepsin

Approved for

• Lymphoma
• Cutaneous T-cell Lymphoma (CTCL)

Drug name(s)

Ropeginterferon alfa-2b-njft Besremi®

Approved for

• Polycythemia Vera

Drug name(s)

Jakafi® Ruxolitinib

Approved for

• Essential Thrombocythemia
• Primary Myelofibrosis
• Polycythemia Vera

Drug name(s)

Leukine ® GM-CSF Sargramostim

Approved for

• Leukemia
• Acute Myeloid Leukemia (AML)

Drug name(s)

Xpovio® Selinexor

Approved for

• Lymphoma
• Diffuse Large B-cell Lymphoma (DLBCL) 
• Follicular Lymphoma (FL) 
• Myeloma

Drug name(s)

Sonrotoclax Beqalzi™

Approved for

• Mantle Cell Lymphoma (MCL) 

Drug name(s)

Monjuvi® Tafasitamab-cxix

Approved for

• Lymphoma
• Diffuse Large B-cell Lymphoma (DLBCL) 

Drug name(s)

Elzonris™ Tagraxofusp-erzs

Approved for

• Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Drug name(s)

Talquetamab-tgvs Talvey™

Approved for

• Myeloma

Drug name(s)

Tecvayli™ Teclistamab-cqyv

Approved for

• Myeloma

Drug name(s)

Vumon® VM-26 Teniposide

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Lymphoma
• Non-Hodgkin Lymphoma (NHL)
• Other Blood Cancers

Drug name(s)

Thalomid® Thalidomide

Approved for

• Myeloma
• Myelodysplastic Syndromes (MDS)

Drug name(s)

Kymriah® Tisagenlecleucel

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Lymphoma
• Diffuse Large B-cell Lymphoma (DLBCL) 
• Follicular Lymphoma (FL) 

Drug name(s)

Actemra® Tocilizumab

Approved for

• Other Blood Cancers

Drug name(s)

Hycamtin® Topotecan

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Acute Myeloid Leukemia (AML)

Drug name(s)

Vesanoid® ATRA Tretinoin All-trans retinoic acid (ATRA)

Approved for

• Leukemia
• Acute Myeloid Leukemia (AML)
• Acute promyelocytic leukemia (APL)

Drug name(s)

Zelboraf® Vemurafenib

Approved for

• Other Blood Cancers

Drug name(s)

Venclexta® Venetoclax

Approved for

• Leukemia
• Acute Myeloid Leukemia (AML)
• Chronic Lymphocytic Leukemia (CLL/SLL)

Drug name(s)

Velban® Vinblastine

Approved for

• Leukemia
• Lymphoma
• Other Blood Cancers

Drug name(s)

Oncovin® Vincristine

Approved for

• Other Blood Cancers

Drug name(s)

Zolinza® Vorinostat

Approved for

• Lymphoma
• Cutaneous T-cell Lymphoma (CTCL)

Drug name(s)

Brukinsa® Zanubrutinib

Approved for

• Leukemia
• Chronic Lymphocytic Leukemia (CLL/SLL)
• Lymphoma
• Follicular Lymphoma (FL) 
• Mantle Cell Lymphoma (MCL) 
• Marginal Zone Lymphoma (MZL) 
• Waldenström Macroglobulinemia (WM)